News
Nektar Therapeutics Receives Letter That It Has Regained Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq Capital Market - Filing
17 Apr 24
News
12 Health Care Stocks Moving In Thursday's Intraday Session
11 Apr 24
Movers
Jefferies Maintains Hold on Nektar Therapeutics, Raises Price Target to $1
6 Mar 24
News, Price Target, Analyst Ratings
Nektar Therapeutics Announces Initiation Of Phase 2b Clinical Study Evaluating Rezpegaldesleukin In Patients With Severe To Very Severe Alopecia Areata
5 Mar 24
Biotech, News, General
Nektar Therapeutics Q4 2023 GAAP EPS $(0.22) Beats $(0.23) Estimate, Sales $23.89M Beat $18.05M Estimate
4 Mar 24
Earnings, Earnings Beats, News
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
4 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Nektar Therapeutics Announces $30M Private Placement Financing With TCGX; Nektar Is Selling 25M Shares Of Its Common Stock, In The Form Of A Pre-Funded Warrant, At A Price Of $1.20 Per Share
4 Mar 24
News, Offerings
Earnings Scheduled For March 4, 2024
4 Mar 24
Earnings
Nektar Therapeutics Earnings Preview
1 Mar 24
Earnings
Press releases
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
22 Mar 24
Press Releases
Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results
4 Mar 24
Press Releases
Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX
4 Mar 24
Press Releases
Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference
27 Feb 24
Press Releases
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets
26 Feb 24
Press Releases